Frédérique Spyratos

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER

Frédérique Spyratos, K. Hacène, Jacques Rouëssé et al. · The Lancet · 1989 · 320 citations

Medicine, Cancer Biology, Oncology +12

Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.

Martine Perrot‐Applanat, Marie‐Thérèse Groyer‐Picard, Frédéric Lorenzo et al. · PubMed · 1987 · 118 citations

Medicine, Endocrinology, Oncology +14

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

Sabine Maier, Inko Nimmrich, Thomas Koenig et al. · European Journal of Cancer · 2007 · 114 citations

Medicine, Molecular Genetics, Oncology +17

PIK3R1 underexpression is an independent prognostic marker in breast cancer

Magdalena Čížková, Sophie Vacher, Didier Meseure et al. · BMC Cancer · 2013 · 111 citations · Full text

Medicine, Genetics, Oncology +17